• 1. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 2. An arsenic trioxide nanoparticle prodrug (ATONP) potentiates a therapeutic effect on an aggressive hepatocellular carcinoma model via enhancement of intratumoral arsenic accumulation and disturbance of the tumor microenvironment?
  Xin Fu,Qing-rong Liang,Rong-guang Luo,Yan-shu Li,Xiao-ping Xiao,Lu-lu Yu,Wen-zhe Shan,Guang-qin Fan J. Mater. Chem. B, 2019,7, 3088-3099
• 3. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
• 4. An alternative biorefinery approach to address microalgal seasonality: blending with spent coffee grounds
  Andre Prates Pereira,Tao Dong,Eric P. Knoshaug,Nick Nagle,Ryan Spiller,Bonnie Panczak,Christopher J. Chuck,Philip T. Pienkos Sustainable Energy Fuels, 2020,4, 3400-3408
• 5. An amorphous Cu–In–S nanoparticle-based precursor ink with improved atom economy for CuInSe2 solar cells with 10.85% efficiency?
  Green Chem., 2017,19, 1268-1277

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acid esters
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Benzoic acid esters

Ethyl 2-chloro-5-(trifluoromethyl)benzoate (CAS No. 162938-44-5): A Comprehensive Overview

Ethyl 2-chloro-5-(trifluoromethyl)benzoate, identified by its CAS number 162938-44-5, is a significant compound in the realm of organic chemistry and pharmaceutical research. This compound belongs to the class of esters and exhibits a unique structural framework that makes it a valuable intermediate in the synthesis of various bioactive molecules. The presence of both chloro and trifluoromethyl substituents on the benzene ring imparts distinct electronic and steric properties, which are highly relevant in medicinal chemistry.

The chemical structure of Ethyl 2-chloro-5-(trifluoromethyl)benzoate consists of a benzoate ester moiety linked to an ethyl group, with a chloro substituent at the 2-position and a trifluoromethyl group at the 5-position of the aromatic ring. This arrangement not only enhances the compound's reactivity but also its potential biological activity. The trifluoromethyl group, in particular, is known for its ability to modulate metabolic stability and binding affinity, making it a popular choice in drug design.

In recent years, there has been growing interest in the development of novel therapeutic agents derived from halogenated aromatic compounds. The study of Ethyl 2-chloro-5-(trifluoromethyl)benzoate has contributed significantly to this field. Researchers have explored its utility as a precursor in the synthesis of various pharmacophores, including those targeting inflammatory diseases, cancer, and infectious disorders. The compound's ability to serve as a versatile building block has been highlighted in several synthetic strategies reported in leading scientific journals.

One notable application of Ethyl 2-chloro-5-(trifluoromethyl)benzoate is in the development of small-molecule inhibitors. For instance, studies have demonstrated its role in synthesizing compounds that interact with specific enzyme targets involved in metabolic pathways. These inhibitors have shown promise in preclinical trials for conditions such as obesity and type 2 diabetes. The incorporation of both chloro and trifluoromethyl groups has been found to enhance binding interactions with biological targets, leading to improved efficacy.

The synthesis of Ethyl 2-chloro-5-(trifluoromethyl)benzoate involves well-established organic reactions, including esterification and halogenation processes. Advanced synthetic methodologies have been employed to optimize yield and purity, ensuring that the final product meets stringent pharmaceutical standards. Techniques such as palladium-catalyzed cross-coupling reactions have been utilized to introduce the trifluoromethyl group efficiently. These advancements underscore the compound's importance in modern synthetic chemistry.

The pharmacological profile of derivatives derived from Ethyl 2-chloro-5-(trifluoromethyl)benzoate has been extensively studied. Computational modeling and experimental assays have provided insights into their mechanism of action. For example, certain analogs have exhibited anti-inflammatory properties by inhibiting key signaling pathways involved in immune responses. Additionally, structural modifications have led to compounds with enhanced selectivity, reducing off-target effects and improving therapeutic outcomes.

The environmental impact and safety considerations of working with Ethyl 2-chloro-5-(trifluoromethyl)benzoate are also important aspects to address. While this compound is not classified as a hazardous material under standard regulations, proper handling procedures must be followed to ensure safety in laboratory settings. Waste disposal methods must adhere to environmental guidelines to minimize ecological impact. These practices align with broader efforts in green chemistry to promote sustainable chemical synthesis.

The future prospects for research involving Ethyl 2-chloro-5-(trifluoromethyl)benzoate remain promising. Ongoing studies aim to uncover new applications in drug discovery and material science. Collaborative efforts between academia and industry are expected to drive innovation, leveraging the compound's unique properties for developing next-generation therapeutics. As our understanding of molecular interactions evolves, so too will the applications of this versatile intermediate.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)